Provided by Tiger Trade Technology Pte. Ltd.

Monopar Therapeutics

107.72
-3.1600-2.85%
Post-market: 107.00-0.7200-0.67%19:30 EDT
Volume:176.42K
Turnover:19.15M
Market Cap:719.85M
PE:-49.40
High:113.46
Open:111.98
Low:105.42
Close:110.88
52wk High:124.82
52wk Low:29.18
Shares:6.68M
Float Shares:4.48M
Volume Ratio:0.81
T/O Rate:3.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1804
EPS(LYR):-1.8509
ROE:-19.50%
ROA:-14.64%
PB:5.50
PE(LYR):-58.20

Loading ...

Morgan Stanley Keeps Their Buy Rating on Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
May 18

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 15

Analysts Are Bullish on These Healthcare Stocks: Aquestive Therapeutics (AQST), Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
May 15

Monopar Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 15

Monopar Therapeutics Q1 EPS $(0.46) Beats $(0.83) Estimate

Benzinga Earnings
·
May 15

Monopar net loss widens to $3.89 million in Q1 FY26

Reuters
·
May 15

Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

THOMSON REUTERS
·
May 15

Monopar Therapeutics Inc - on Track to Submit Nda to FDA in Mid-2026

THOMSON REUTERS
·
May 15

Monopar Therapeutics Inc expected to post a loss of 84 cents a share - Earnings Preview

Reuters
·
May 08

Monopar Therapeutics announces annual shareholder meeting

Reuters
·
May 01

Analysts Offer Insights on Healthcare Companies: Monopar Therapeutics Inc (MNPR), ClearPoint Neuro (CLPT) and CG Oncology, Inc. (CGON)

TIPRANKS
·
Apr 21

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Whitehawk Therapeutics (WHWK), COMPASS Pathways (CMPS) and Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
Apr 21

Monopar announces new analyses from Phase 3 FoCus trial of ALXN1840

TIPRANKS
·
Apr 20

Monopar says Phase 3 trial shows ALXN1840 beats standard care in neurologic Wilson disease

Reuters
·
Apr 20

Monopar Therapeutics Inc (MNPR) Gets a Buy from JonesTrading

TIPRANKS
·
Apr 07

Monopar Therapeutics Inc (MNPR) Receives a Buy from Lake Street

TIPRANKS
·
Mar 30

Monopar Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 30

Monopar Therapeutics Is Maintained at Buy by Chardan Capital

Dow Jones
·
Mar 30

Monopar Therapeutics Q4 net loss narrows on lower R&D costs

Reuters
·
Mar 28

Monopar Therapeutics Q4 EPS $(0.61) Misses $(0.54) Estimate

Benzinga Earnings
·
Mar 28